All the news Showing 10 of 63 articles from: FranceGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Transmission and prevention New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands Liz Highleyman / 17 February 2017 A little more than a year after the Netherlands instituted a policy allowing unrestricted access to direct-acting antivirals for the treatment of hepatitis C, researchers have already seen a dramatic decline in acute ... Sexual transmission Hepatitis C infection and reinfection among men who have sex with men Liz Highleyman / 29 September 2016 Public health officials in Michigan have identified a cluster of more than 20 cases of apparently sexually transmitted hepatitis C virus (HCV) infection among HIV-positive gay and bisexual men, according to a report ... Access to medicines & diagnostics France to provide universal access to hepatitis C treatment Keith Alcorn / 01 June 2016 France will provide access to hepatitis C treatment with direct-acting antivirals to everyone diagnosed with hepatitis C from September 2016, and will begin to provide treatment to everyone with stage 2 fibrosis immediately, ... Sexual transmission High incidence of HCV reinfection among HIV-positive MSM in Western Europe Michael Carter / 19 April 2016 There is a very high incidence of hepatitis C virus (HCV) reinfection among HIV-positive men who have sex with men (MSM) in western Europe, according to research presented to the International Liver Congress ... Access to medicines & diagnostics European Physicians Report Strong but Variable Uptake of All-Oral Interferon-Free Hepatitis C Virus Regimens Across EU5 Countries Decision Resources press release / 09 December 2015 Treatment outcomes Clinical impact of effective HCV DAAs: referrals for liver transplant drop after their introduction Keith Alcorn / 04 December 2015 The number of hepatitis C virus (HCV)-related referrals for liver transplant has declined significantly since the introduction of HCV direct-acting antivirals (DAAs), according to two US studies presented to the recent 2015 ... Treatment for people living with HIV and HCV Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme Liz Highleyman / 05 August 2015 Interferon-free treatment using daclatasvir (Daklinza) and sofosbuvir (Sovaldi), with or without ribavirin, was well-tolerated and produced sustained virological response rates of 95-100% for people with HIV and HCV co-infection and advanced liver disease, ... Harm reduction interventions and policy First French Cities Apply for Drug Consumption Rooms Under New Law Talking Drugs / 12 May 2015 Transmission and prevention High Cure Rates Will Not Curb Hepatitis C, Expert Warns Medscape / 05 May 2015 Prognosis and disease progression Alcohol misuse the strongest predictor of severe liver damage and death in French people with hepatitis C Keith Alcorn / 28 April 2015 People with hepatitis C have a much greater risk of liver-related hospitalisation or death if they have an alcohol use disorder or another serious co-morbidity such as HIV infection, chronic kidney disease ... ← Prev1...23456...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive